PREVENA 125 and PREVENA PLUS 125 Therapy Units
Negative Pressure Wound Therapy Device For Reduction Of Wound Complications. De Novo DEN180013, from Kci USA, Inc. (San Antonio, TX). Product code QFC, class 2.
As of Nov 21, 2026, DEN180013 is an FDA De Novo held by Kci USA, Inc., granted on Apr 19, 2019 after 400 days, with no recalls tied to it in FDA's recall database.
- Review time: 400 days
- Recalls: 0
- Cited as a predicate by: 1 device
PREVENA 125 and PREVENA PLUS 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure.
- Design
- Systematic literature review and meta-analysis of 20 prospective studies (SSI and seroma) vs. conventional dressings
- Enrolled
- 6,403
- Primary endpoint
- Incidence of surgical site infection within 30 days (SSI meta-analysis); incidence of seroma at 10 days (seroma meta-analysis)
- Result
- SSI pooled OR 0.37 (95% CI 0.27-0.52) favoring PREVENA; seroma pooled OR 0.31 (0.13-0.75); text states statistical significance cannot be reliably inferred
- Prevena Plus 125 Therapy UnitK223263 · 3M · Feb 13, 2023
- PICO 7 Single Use Negative Pressure Wound Therapy System;PICO 14 Single Use Negative Pressure Wound Therapy System;PICO…K263567 · Smith and Nephew Medical Limited · Nov 6, 2026
- Prevena Plus 125 Therapy UnitK223263 · 3M · Feb 13, 2023
- PICO Single Use Negative Pressure Wound Therapy System, PICO 7 Single Use Negative Pressure Wound Therapy System, PICO…K203716 · Smith and Nephew Medical Limited · Dec 14, 2021
- Type
- Direct
- Received
- Mar 15, 2018
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.4783
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files